Janux Therapeutics, Inc.

Direct answer

Janux Therapeutics, Inc. is publicly traded on NASDAQ under the ticker JANX.

Janux Therapeutics, Inc. is a biopharmaceutical company dedicated to developing innovative cancer therapies. The firm leverages its proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to create treatments designed to activate the body's T cells to fight tumors. Currently, Janux has several promising TRACTr product candidates in their early preclinical or discovery stages, which are engineered to...

Can you invest in Janux Therapeutics, Inc.?

Yes. Janux Therapeutics, Inc. is publicly traded on NASDAQ under the ticker JANX.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Janux Therapeutics, Inc.

Detailed equity research is provided by MarketSnap.